APA

Decochez K., Truyen I., van der Auwera B., Weets I., Vandemeulebroucke E., de Leeuw I. H., Keymeulen B., Mathieu C., Rottiers R., Pipeleers D. G. & Gorus F. K. (20050906). Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes. : Diabetologia.

Chicago

Decochez K, Truyen I, van der Auwera B, Weets I, Vandemeulebroucke E, de Leeuw I H, Keymeulen B, Mathieu C, Rottiers R, Pipeleers D G and Gorus F K. 20050906. Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes. : Diabetologia.

Harvard

Decochez K., Truyen I., van der Auwera B., Weets I., Vandemeulebroucke E., de Leeuw I. H., Keymeulen B., Mathieu C., Rottiers R., Pipeleers D. G. and Gorus F. K. (20050906). Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes. : Diabetologia.

MLA

Decochez K, Truyen I, van der Auwera B, Weets I, Vandemeulebroucke E, de Leeuw I H, Keymeulen B, Mathieu C, Rottiers R, Pipeleers D G and Gorus F K. Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes. : Diabetologia. 20050906.